Showing results (1-10 of 156) with videos related to
Sort By:
Pageof 16
Journal of Health Care for the Poor and Underserved|January 8, 2021
Improving Hepatitis B Care in the US: A Case for a New "Ryan White" ProgramJonathan D Alpern, Thomas M Leventhal, Nathan C BahrOpen Forum Infectious Diseases|April 3, 2023
Factors Associated With Adherence to First-line Antiviral Therapy Among Commercially Insured Patients With Chronic Hepatitis BJonathan D Alpern, Heesoo Joo, Nathan C Bahr, et al.Journal of Fungi (Basel, Switzerland)|August 26, 2022
Blastomycosis-Some Progress but Still Much to LearnMatthew F Pullen, Jonathan D Alpern, Nathan C BahrMycoses|June 20, 2022
Antifungal drug price increases in the United States, 2000-2019Christine M Thomas, Whitney Shae, Devin Koestler, et al.Open Forum Infectious Diseases|July 16, 2016
Diagnostic Delay and Antibiotic Overuse in Acute Pulmonary BlastomycosisJonathan D Alpern, Nathan C Bahr, Gabriela Vazquez-Benitez, et al.Journal of Health Care for the Poor and Underserved|September 1, 2015
The Effect of Structural Violence on Patients with Sickle Cell DiseaseNathan C Bahr, John SongFrontiers in Sociology|April 19, 2021
Antiparasitic Drugs in the United States-Two Roads to High PricesArman A Shahriar, Jonathan D AlpernBiomarkers in Medicine|November 18, 2014
Methods of rapid diagnosis for the etiology of meningitis in adultsNathan C Bahr, David R BoulwareCurrent Opinion in Infectious Diseases|September 27, 2023
Endemic mycoses - are we making progress in management?Nathan C Bahr, George R ThompsonJournal of Managed Care & Specialty Pharmacy|October 1, 2021
Drug-dispensing limits within Medicaid during the COVID-19 pandemicJonathan D Alpern, Nathan Chomilo, Malini DeSilvaPageof 16